Published in Ann N Y Acad Sci on July 23, 1965
Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus. Nat Immunol (2013) 2.55
A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun (1996) 2.13
The hemolysins of Staphylococcus aureus. Bacteriol Rev (1975) 1.77
Structural analysis of the cellular constituents of a fresh clinical isolate of Staphylococcus aureus, and their role in the interaction between the organisms and polymorphonuclear leukocytes in the presence of serum factors. Infect Immun (1978) 1.43
Staphylococcal manipulation of host immune responses. Nat Rev Microbiol (2015) 1.42
Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio (2013) 1.26
Immunological specificity of heat-stable opsonins in immune and nonimmune sera and their interaction with non-encapsulated and encapsulated strains of Staphylococcus aureus. Infect Immun (1979) 1.18
Isolation of an acidic surface antigen from a conventional strain of Staphylococcus aureus. Infect Immun (1974) 1.09
Immunochemical study of diverse surface antigens of a Staphylococcus aureus isolate from an osteomyelitis patient and their role in in vitro phagocytosis. J Clin Microbiol (1979) 1.08
Nitric oxide mediated Staphylococcus aureus pathogenesis and protective role of nanoconjugated vancomycin. Asian Pac J Trop Biomed (2011) 0.98
Internalization of Staphylococcus aureus in lymphocytes induces oxidative stress and DNA fragmentation: possible ameliorative role of nanoconjugated vancomycin. Oxid Med Cell Longev (2011) 0.87
The role of humoral immunity and acute inflammation in protection against staphyloccocal dermonecrosis. Immunology (1975) 0.84
Staphylococcus aureus vaccines: Deviating from the carol. J Exp Med (2016) 0.82
Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection. Infect Immun (2014) 0.80
Generation of a Novel Staphylococcus aureus Ghost Vaccine and Examination of Its Immunogenicity against Virulent Challenge in Rats. Infect Immun (2015) 0.80
Activation of the alternate complement pathway in Staph. aureus infective endocarditis and its relationship to thrombocytopenia, coagulation abnormalities, and acute glomerulonephritis. Clin Exp Immunol (1978) 0.79
Staphylococcal bacteremia: demographic, clinical and mirobiological features of 185 cases. Trans Am Clin Climatol Assoc (1968) 0.77
Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs. MBio (2015) 0.76
Vaccines for Healthcare-associated Infections: Promise and Challenge. Clin Infect Dis (2016) 0.75
Shattuck lecture--the American health-care scene. Views from a foundation perspective. N Engl J Med (1973) 4.36
The contribution of specialists to the delivery of primary care. N Engl J Med (1979) 4.03
Who needs Medicaid? N Engl J Med (1982) 2.60
Biological properties of the encapsulated Staphylococcus aureus M. Infect Immun (1974) 2.58
Medical technology -- a different view of the contentious debate over costs. N Engl J Med (1979) 2.48
The importance of surface antigens in staphylococcal virulence. Ann N Y Acad Sci (1965) 2.35
Patient-physician covenant. JAMA (1995) 2.29
Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy. Am J Med (1968) 2.18
The academic medical center: a stressed American institution. N Engl J Med (1978) 1.98
Bactericidal effects of polyunsaturated fatty acids. J Infect Dis (1986) 1.96
An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis (1976) 1.95
Studies on human leukocyte motility. I. Effects of alterations in pH, electrolyte concentration, and phagocytosis on leukocyte migration, adhesiveness, and aggregation. J Exp Med (1966) 1.93
Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J Infect Dis (1984) 1.91
Unrecognized durotomy after lumbar discectomy: a report of four cases associated with the use of ADCON-L. Spine (Phila Pa 1976) (2001) 1.76
Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies. Yale J Biol Med (1967) 1.75
A private sector view of public health today. Am J Public Health (1974) 1.71
Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis (1981) 1.70
Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users. Ann Intern Med (1989) 1.65
Surface polysaccharide from Staphylococcus aureus M that contains taurine, D-aminogalacturonic acid, and D-fucosamine. J Bacteriol (1974) 1.64
On preparing academic health centers for the very different 1980s. J Med Educ (1980) 1.58
Sepsis caused by contaminated intravenous fluids. Epidemiologic, clinical, and laboratory investigation of an outbreak in one hospital. Ann Intern Med (1972) 1.31
Studies of toxicity of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis (1981) 1.26
Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies. Yale J Biol Med (1967) 1.23
Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg (1975) 1.19
Community-oriented primary care. JAMA (1982) 1.17
The repeating sequence of the capsular polysaccharide of Staphylococcus aureus M. Carbohydr Res (1983) 1.16
Social ramifications of control of microbial disease. Johns Hopkins Med J (1982) 1.12
Clear acrylic resin T-bar used in denture identification. J Prosthet Dent (1993) 1.11
Host species-specific damage to oviduct mucosa by Neisseria gonorrhoeae lipopolysaccharide. Infect Immun (1981) 1.08
The changing American health scene. Sometimes things get better. JAMA (1977) 1.05
Studies on human leukocyte motility. II. Effects of bacterial endotoxin on leukocyte migration, adhesiveness, and aggregation. Yale J Biol Med (1967) 1.05
Some musings on medical education: Is it going astray? Pharos Alpha Omega Alpha Honor Med Soc (1982) 1.04
Health indicators for an aging population. Vital Health Stat 4 (1988) 1.01
Federal spending on AIDS--how much is enough? N Engl J Med (1989) 0.99
Serum factors and the reticuloendothelial uptake of Staphylococcus aureus. I. The role of whole serum. J Immunol (1968) 0.99
Type B botulism in man. Am J Med (1967) 0.98
Analysis of damage to human ciliated nasopharyngeal epithelium by Neisseria meningitidis. Infect Immun (1986) 0.97
Who should give primary care? The continuing debate. N Engl J Med (1981) 0.96
Improving health and medical care in the United States: a foundation's early experience. J Ambul Care Manage (1983) 0.95
Gonococcal lipopolysaccharide: a toxin for human fallopian tube mucosa. Am J Obstet Gynecol (1980) 0.95
Gram-negative bacillary sepsis associated with use of lipid emulsion in parenteral nutrition. Am J Dis Child (1979) 0.94
An electron microscopic India ink technique for demonstrating capsules on microorganisms: studies with Streptococcus pneumoniae, Staphylococcus aureus, and Neisseria gonorrhoeae. J Infect Dis (1979) 0.94
The shortage of hospital nurses: a new perspective. Ann Intern Med (1981) 0.93
Attachment of pathogenic Neisseria to human mucosal surfaces: role in pathogenesis. Infection (1982) 0.93
One medical school's involvement in new health care delivery models. Its problems and its pleasures. Arch Intern Med (1971) 0.92
AIDS in New York City: the role of intravenous drug users. Bull N Y Acad Med (1989) 0.91
Localization of gonococcal lipopolysaccharide and its relationship to toxic damage in human fallopian tube mucosa. Infect Immun (1986) 0.91
An era of stress for health institutions. The 1980s. JAMA (1981) 0.91
Technology's consort. Am J Med (1983) 0.89
Some observations on pediatrics: Its past, present, and future. Pediatrics (1981) 0.88
Some reflections on medicine today and tomorrow. Ann Intern Med (1969) 0.88
Subperiosteal hematomas of the orbit: angiographic and computed tomographic diagnosis. Radiology (1982) 0.88
Medical academy and the problems of health care provision. Arch Intern Med (1975) 0.84
New York City's health care crisis: AIDS, the poor, and limited resources. JAMA (1988) 0.84
Studies on isolated cultured rabbit Kupffer cells. J Reticuloendothel Soc (1972) 0.84
Cutting medical care costs. Primum non nocere. JAMA (1983) 0.84
The impact of new community health programs on one medical teaching institution. Perspect Biol Med (1972) 0.84
The formation and properties of wheat flour doughs. Crit Rev Food Sci Nutr (1990) 0.83
The hemodynamic effects of viable gram-negative organisms. Surg Gynecol Obstet (1969) 0.83
Research and development in new health care programs, an expanded Hopkins mission. Introduction. Johns Hopkins Med J (1971) 0.83
The hepatic uptake of bacterial endotoxin. I. The influence of humoral and cellular factors. Proc Soc Exp Biol Med (1969) 0.82
The problem of gram-negative bacteremia and its management. South Med J (1965) 0.81
Further observations on the mechanism of reticuloendothelial blockade. J Exp Med (1967) 0.81
The bright spot about AIDS: it is very tough to catch. AIDS (1990) 0.80
The arthroscopic drainage, irrigation, and débridement of late, acute total hip arthroplasty infections: average 6-year follow-up. J Arthroplasty (1999) 0.80
Where have we been? Where are we going? Daedalus (1986) 0.79
Evaluating a private foundation's health program. Eval Program Plann (1980) 0.78
Another approach to the AIDS epidemic. N Engl J Med (1991) 0.77
The early years: the medical world in which Walsh McDermott trained. Daedalus (1986) 0.77
One approach to care for patients infected with human immunodeficiency virus in an academic medical center. Bull N Y Acad Med (1996) 0.77
The challenge of primary care. Daedalus (1977) 0.76
Primary care: some issues. Bull N Y Acad Med (1977) 0.76
Internists: more specialists or more generalists? Ann Intern Med (1985) 0.76
Nursery epidemic due to multiply-resistant Klebsiella pneumoniae: epidemiologic setting and impact on perinatal health care delivery. Infect Control (1982) 0.75
Human immunodeficiency virus infection and tuberculosis: an analysis and a course of action. Bull N Y Acad Med (1994) 0.75
Statement on the risk of contracting HIV infections in the course of health care. Bull N Y Acad Med (1991) 0.75
Report card on our national response to the AIDS epidemic--some A's, too many D's. Am J Public Health (1992) 0.75
Thoughts on the academic center in the 1980s. Bull N Y Acad Med (1981) 0.75
On iron men in wooden ships: some thoughts on house staff training--1984. Trans Am Clin Climatol Assoc (1985) 0.75
Setting of priorities for health care delivery. Clin Res (1977) 0.75
HIV tests of doctors won't shield patients from AIDS. Med Econ (1991) 0.75
They call it claims processing. I call it fraud against doctors. Med Econ (1999) 0.75
Forces affecting dental education. J Dent Educ (1979) 0.75
Thoughts on the future of medicine. Bull N Y Acad Med (1989) 0.75
Denture labels affixed with light-cured versus self-cured resin. J Indiana Dent Assoc (1994) 0.75
The stalled response to AIDS. Issues Sci Technol (1992) 0.75
Yes, but what do internists really do? Ann Intern Med (1979) 0.75
The twin responsibility of the physician in disease and illness. Isr J Med Sci (1977) 0.75
HCMR interview: David E. Rogers. Health Care Manage Rev (1980) 0.75
Letter: The Robert Wood Johnson Foundation. J Community Health (1976) 0.75
David Preswick Barr 1889-1977. Trans Assoc Am Physicians (1978) 0.75
Similarities in coronary flow between external counterpulsation and intra-aortic balloon pumping. Am J Physiol (1976) 0.75
Illness must be understood not in scientific but in human terms. Va Med Q (1995) 0.75
AIDS in the United States: patient care and politics. Daedalus (1989) 0.75
On preparing academic health centers for the very different 1980s. J Dent Educ (1980) 0.75
Preservation prescription given for academic health care centers. Natl Underwrit Life Health (1979) 0.75
Some reflections on foundation building. Health Aff (Millwood) (1987) 0.75
General medical care in America: a generalist-specialist mix. Am J Med (1980) 0.75
37th annual Charles V. Chapin Oration. The scorecard: how are we doing in health care in America? R I Med J (1979) 0.75